pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4323 |
Genomic Coordinates | chr19: 42133445 - 42133513 |
Description | Homo sapiens miR-4323 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4323 | ||||||||||||||||||
Sequence | 42| CAGCCCCACAGCCUCAGA |59 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | AGRN | ||||||||||||||||||||
Synonyms | AGRIN, CMS8, CMSPPD | ||||||||||||||||||||
Description | agrin | ||||||||||||||||||||
Transcript | NM_198576 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on AGRN | |||||||||||||||||||||
3'UTR of AGRN (miRNA target sites are highlighted) |
>AGRN|NM_198576|3'UTR 1 GCTGGCACCAGAGCCCCGCGCCCGCTGTAATTATTTTCTATTTTTGTAAACTTGTTGCTTTTTGATATGATTTTCTTGCC 81 TGAGTGTTGGCCGGAGGGACTGCTGGCCCGGCCTCCCTTCCGTCCAGGCAGCCGTGCTGCAGACAGACCTAGTGCCGAGG 161 GATGGACAGGCGAGGTGGCAGCGTGGAGGGCTCGGCGTGGATGGCAGCCTCAGGACACACACCCCTGCCTCAAGGTGCTG 241 AGCCCCCGCCTTGCACTGCGCCTGCCCCACGGTGTCCCCGCCGGGAAGCAGCCCCGGCTCCTGAATCACCCTCGCTCCGT 321 CAGGCGGGACTCGTGTCCCAGAGAGGAAGGGGCTGCTGAGGTCTGATGGGGCCCTTCCTCCGGGTGACCCCACAGGGCCT 401 TTCCAAGCCCCCATTTGAGCTGCTCCTTCCTGTGTGTGCTCTGGGCCCTGCCTCGGCCTCCTGCGCCAATACTGTGACTT 481 CCAAACAATGTTACTGCTGGGCACAGCTCTGCGTTGCTCCCGTGCTGCCTGCGCCAGCCCCAGGCTGCTGAGGAGCAGAG 561 GCCAGACCAGGGCCGATCTGGGTGTCCTGACCCTCAGCTGGCCCTGCCCAGCCACCCTGGACGTGACCGTATCCCTCTGC 641 CACACCCCAGGCCCTGCGAGGGGCTATCGAGAGGAGCTCACTGTGGGATGGGGTTGACCTCTGCCGCCTGCCTGGGTATC 721 TGGGCCTGGCCATGGCTGTGTTCTTCATGTGTTGATTTTATTTGACCCCTGGAGTGGTGGGTCTCATCTTTCCCATCTCG 801 CCTGAGAGCGGCTGAGGGCTGCCTCACTGCAAATCCTCCCCACAGCGTCAGTGAAAGTCGTCCTTGTCTCAGAATGACCA 881 GGGGCCAGCCAGTGTCTGACCAAGGTCAAGGGGCAGGTGCAGAGGTGGCAGGGATGGCTCCGAAGCCAGAAATGCCTTAA 961 ACTGCAACGTCCCGTCCCTTCCCCACCCCCATCCCATCCCCACCCCCAGCCCCAGCCCAGTCCTCCTAGGAGCAGGACCC 1041 GATGAAGCGGGCGGCGGTGGGGCTGGGTGCCGTGTTACTAACTCTAGTATGTTTCTGTGTCAATCGCTGTGAAATAAAGT 1121 CTGAAAACTTTAAAAGCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_198576 | 3UTR | AGGAGCAGGACCCGAUGAAGCGGGCGGCGGUGGGGCUGGGUGCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903826 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_NS |
Location of target site | NM_198576 | 3UTR | AGGACCCGAUGAAGCGGGCGGCGGUGGGGCUGGGUGCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000379370.2 | 3UTR | GCGGGCGGCGGUGGGGCUGGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
64 hsa-miR-4323 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052834 | NOL11 | nucleolar protein 11 | 1 | 1 | ||||||||
MIRT082489 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT117166 | PER1 | period circadian clock 1 | 2 | 2 | ||||||||
MIRT157951 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT286013 | TVP23B | trans-golgi network vesicle protein 23 homolog B | 2 | 2 | ||||||||
MIRT310457 | REST | RE1 silencing transcription factor | 2 | 2 | ||||||||
MIRT338984 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT404223 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT451439 | TJP3 | tight junction protein 3 | 2 | 2 | ||||||||
MIRT463541 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT466981 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT479627 | CDC25A | cell division cycle 25A | 2 | 2 | ||||||||
MIRT487983 | SEC14L3 | SEC14 like lipid binding 3 | 2 | 4 | ||||||||
MIRT488661 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT489925 | RTKN | rhotekin | 2 | 2 | ||||||||
MIRT490209 | PKNOX2 | PBX/knotted 1 homeobox 2 | 2 | 2 | ||||||||
MIRT494896 | ZNF662 | zinc finger protein 662 | 2 | 2 | ||||||||
MIRT495380 | RELT | RELT, TNF receptor | 2 | 2 | ||||||||
MIRT495549 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT499104 | AGRN | agrin | 2 | 2 | ||||||||
MIRT500036 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 8 | ||||||||
MIRT501135 | SLC2A1 | solute carrier family 2 member 1 | 2 | 2 | ||||||||
MIRT505573 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT508164 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 8 | ||||||||
MIRT512383 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT512719 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT520904 | STMN1 | stathmin 1 | 2 | 2 | ||||||||
MIRT526361 | TIMMDC1 | translocase of inner mitochondrial membrane domain containing 1 | 2 | 2 | ||||||||
MIRT526847 | GALNT11 | polypeptide N-acetylgalactosaminyltransferase 11 | 2 | 2 | ||||||||
MIRT526945 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 4 | ||||||||
MIRT527028 | PABPN1L | poly(A) binding protein nuclear 1 like, cytoplasmic | 2 | 2 | ||||||||
MIRT527988 | TSLP | thymic stromal lymphopoietin | 2 | 2 | ||||||||
MIRT532202 | MPDU1 | mannose-P-dolichol utilization defect 1 | 2 | 2 | ||||||||
MIRT533691 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT535020 | PRMT7 | protein arginine methyltransferase 7 | 2 | 4 | ||||||||
MIRT535054 | PQLC1 | PQ loop repeat containing 1 | 2 | 2 | ||||||||
MIRT538987 | BCL2L2 | BCL2 like 2 | 2 | 2 | ||||||||
MIRT552232 | SART3 | squamous cell carcinoma antigen recognized by T-cells 3 | 2 | 2 | ||||||||
MIRT553259 | TVP23C | trans-golgi network vesicle protein 23 homolog C | 2 | 2 | ||||||||
MIRT555157 | PTPDC1 | protein tyrosine phosphatase domain containing 1 | 2 | 2 | ||||||||
MIRT565202 | TSC22D4 | TSC22 domain family member 4 | 2 | 2 | ||||||||
MIRT566199 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT566526 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT568464 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT572231 | ATG2A | autophagy related 2A | 2 | 2 | ||||||||
MIRT573096 | NDUFA7 | NADH:ubiquinone oxidoreductase subunit A7 | 2 | 2 | ||||||||
MIRT573326 | RFC5 | replication factor C subunit 5 | 2 | 2 | ||||||||
MIRT632802 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT646433 | ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 2 | 3 | ||||||||
MIRT647826 | MTG1 | mitochondrial ribosome associated GTPase 1 | 2 | 4 | ||||||||
MIRT652191 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT653800 | SIRPA | signal regulatory protein alpha | 2 | 2 | ||||||||
MIRT666949 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT684833 | SCAI | suppressor of cancer cell invasion | 2 | 2 | ||||||||
MIRT687294 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT700188 | RIMKLB | ribosomal modification protein rimK like family member B | 2 | 2 | ||||||||
MIRT701784 | MSL2 | MSL complex subunit 2 | 2 | 2 | ||||||||
MIRT705958 | ACY1 | aminoacylase 1 | 2 | 2 | ||||||||
MIRT705998 | ABHD14A-ACY1 | ABHD14A-ACY1 readthrough | 2 | 2 | ||||||||
MIRT717107 | PXDC1 | PX domain containing 1 | 2 | 2 | ||||||||
MIRT717586 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT722148 | SLC2A8 | solute carrier family 2 member 8 | 2 | 2 | ||||||||
MIRT723479 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT725221 | PEA15 | phosphoprotein enriched in astrocytes 15 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|